| Year |
Citation |
Score |
| 2023 |
Shillington A, Zappia KJ, White L, Fosdick C, Erickson CA, Lamy M, Dominick KC. Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatonia. American Journal of Medical Genetics. Part A. PMID 37642312 DOI: 10.1002/ajmg.a.63379 |
0.401 |
|
| 2023 |
Schmitt LM, Smith EG, Pedapati EV, Horn PS, Will M, Lamy M, Barber L, Trebley J, Meyer K, Heiman M, West KHJ, Hughes P, Ahuja S, Erickson CA. Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Scientific Reports. 13: 5192. PMID 36997569 DOI: 10.1038/s41598-023-30909-0 |
0.392 |
|
| 2023 |
Erickson CA, Tessier CR, Gross C, Pedapati EV, Wink LK, Dominick KC, Shaffer RC, Rosselot H, Hong MP, Bantel AP, Berry-Kravis E, Horn PS, Adams R, Sweeney JA. Lymphocytic Extracellular Signal Regulated Kinase Dysregulation in Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 36638885 DOI: 10.1016/j.jaac.2022.09.437 |
0.341 |
|
| 2022 |
Schmitt LM, Li J, Liu R, Horn PS, Sweeney JA, Erickson CA, Pedapati EV. Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome. Molecular Autism. 13: 47. PMID 36494861 DOI: 10.1186/s13229-022-00527-0 |
0.47 |
|
| 2022 |
Jonak CR, Pedapati EV, Schmitt LM, Assad SA, Sandhu MS, DeStefano L, Ethridge L, Razak KA, Sweeney JA, Binder DK, Erickson CA. Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome. Journal of Neurodevelopmental Disorders. 14: 52. PMID 36167501 DOI: 10.1186/s11689-022-09455-9 |
0.385 |
|
| 2022 |
Albizua I, Charen K, Shubeck L, Talboy A, Berry-Kravis E, Kaufmann WE, Stallworth JL, Drazba KT, Erickson CA, Sweeney JA, Tartaglia N, Warren SF, Hagerman R, Sherman SL, Warren ST, et al. Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Molecular Genetics & Genomic Medicine. e2001. PMID 35852003 DOI: 10.1002/mgg3.2001 |
0.346 |
|
| 2022 |
Pedapati EV, Schmitt LM, Ethridge LE, Miyakoshi M, Sweeney JA, Liu R, Smith E, Shaffer RC, Dominick KC, Gilbert DL, Wu SW, Horn PS, Binder DK, Lamy M, Axford M, ... Erickson CA, et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Communications Biology. 5: 442. PMID 35546357 DOI: 10.1038/s42003-022-03395-9 |
0.302 |
|
| 2021 |
Dominick KC, Andrews HF, Kaufmann WE, Berry-Kravis E, Erickson CA. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 31: 659-669. PMID 34818076 DOI: 10.1089/cap.2021.0042 |
0.396 |
|
| 2021 |
Henneberry E, Lamy M, Dominick KC, Erickson CA. Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 34491511 DOI: 10.1007/s10803-021-05237-9 |
0.417 |
|
| 2021 |
Yurkovic JR, Lisandrelli G, Shaffer RC, Dominick KC, Pedapati EV, Erickson CA, Kennedy DP, Yu C. Using head-mounted eye tracking to examine visual and manual exploration during naturalistic toy play in children with and without autism spectrum disorder. Scientific Reports. 11: 3578. PMID 33574367 DOI: 10.1038/s41598-021-81102-0 |
0.332 |
|
| 2020 |
Lamy M, Pedapati EV, Dominick KL, Wink LK, Erickson CA. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents. Paediatric Drugs. PMID 32686015 DOI: 10.1007/s40272-020-00408-0 |
0.447 |
|
| 2020 |
Wink LK, Reisinger DL, Horn P, Shaffer RC, O'Brien K, Schmitt L, Dominick KR, Pedapati EV, Erickson CA. Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders. PMID 32642957 DOI: 10.1007/s10803-020-04542-z |
0.4 |
|
| 2020 |
Shillington A, Lamy M, Vawter-Lee M, Erickson C, Saal H, Comoletti D, Abell K. Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder? Journal of Autism and Developmental Disorders. PMID 32405903 DOI: 10.1007/s10803-020-04531-2 |
0.349 |
|
| 2020 |
Razak KA, Dominick KC, Erickson CA. Developmental studies in fragile X syndrome. Journal of Neurodevelopmental Disorders. 12: 13. PMID 32359368 DOI: 10.1186/S11689-020-09310-9 |
0.318 |
|
| 2020 |
Reisinger DL, Shaffer RC, Tartaglia N, Berry-Kravis E, Erickson CA. Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome. Brain Sciences. 10. PMID 32316611 DOI: 10.3390/brainsci10040239 |
0.457 |
|
| 2020 |
Shaffer RC, Schmitt L, John Thurman A, Abbeduto L, Hong M, Pedapati E, Dominick K, Sweeney J, Erickson C. The Relationship between Expressive Language Sampling and Clinical Measures in Fragile X Syndrome and Typical Development. Brain Sciences. 10. PMID 31991905 DOI: 10.3390/Brainsci10020066 |
0.312 |
|
| 2019 |
Mooney LN, Dominick KC, Erickson CA. Psychopharmacology of neurobehavioral disorders. Handbook of Clinical Neurology. 165: 383-390. PMID 31727225 DOI: 10.1016/B978-0-444-64012-3.00023-X |
0.612 |
|
| 2019 |
Pedapati EV, Mooney LN, Wu SW, Erickson CA, Sweeney JA, Shaffer RC, Horn PS, Wink LK, Gilbert DL. Motor cortex facilitation: a marker of attention deficit hyperactivity disorder co-occurrence in autism spectrum disorder. Translational Psychiatry. 9: 298. PMID 31723120 DOI: 10.1038/S41398-019-0614-3 |
0.6 |
|
| 2019 |
McLane RD, Schmitt LM, Pedapati EV, Shaffer RC, Dominick KC, Horn PS, Gross C, Erickson CA. Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome. Frontiers in Integrative Neuroscience. 13: 49. PMID 31551722 DOI: 10.3389/Fnint.2019.00049 |
0.34 |
|
| 2019 |
Hong MP, Erickson CA. Investigational Drugs in Early Stage Clinical Trials for Autism Spectrum Disorder. Expert Opinion On Investigational Drugs. PMID 31352835 DOI: 10.1080/13543784.2019.1649656 |
0.411 |
|
| 2019 |
Hong MP, Eckert EM, Pedapati EV, Shaffer RC, Dominick KC, Wink LK, Sweeney JA, Erickson CA. Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study. Journal of Neurodevelopmental Disorders. 11: 1. PMID 30665413 DOI: 10.1186/S11689-019-9262-4 |
0.463 |
|
| 2018 |
Will MN, Currans K, Smith J, Weber S, Duncan A, Burton J, Kroeger-Geoppinger K, Miller V, Stone M, Mays L, Luebrecht A, Heeman A, Erickson C, Anixt J. Evidenced-Based Interventions for Children With Autism Spectrum Disorder. Current Problems in Pediatric and Adolescent Health Care. PMID 30337149 DOI: 10.1016/j.cppeds.2018.08.014 |
0.401 |
|
| 2018 |
Lamy M, Erickson CA. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Current Problems in Pediatric and Adolescent Health Care. PMID 30262163 DOI: 10.1016/j.cppeds.2018.08.015 |
0.485 |
|
| 2018 |
Wink LK, Adams R, Horn PS, Tessier CR, Bantel AP, Hong M, Shaffer RC, Pedapati EV, Erickson CA. A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 29644582 DOI: 10.1007/s10803-018-3562-5 |
0.311 |
|
| 2018 |
Øien RA, Vambheim SM, Hart L, Nordahl-Hansen A, Erickson C, Wink L, Eisemann MR, Shic F, Volkmar FR, Grodberg D. Sex-Differences in Children Referred for Assessment: An Exploratory Analysis of the Autism Mental Status Exam (AMSE). Journal of Autism and Developmental Disorders. PMID 29423603 DOI: 10.1007/S10803-018-3488-Y |
0.306 |
|
| 2017 |
Hong MP, Guilfoyle JL, Mooney LN, Wink LK, Pedapati EV, Shaffer RC, Sweeney JA, Erickson CA. Eye gaze and pupillary response in Angelman syndrome. Research in Developmental Disabilities. 68: 88-94. PMID 28750207 DOI: 10.1016/J.Ridd.2017.06.011 |
0.598 |
|
| 2017 |
McClellan L, Dominick KC, Pedapati EV, Wink LK, Erickson CA. Lurasidone for the treatment of irritability and anger in autism spectrum disorders. Expert Opinion On Investigational Drugs. PMID 28685626 DOI: 10.1080/13543784.2017.1353600 |
0.457 |
|
| 2017 |
Budimirovic DB, Berry-Kravis E, Erickson CA, Hall SS, Hessl D, Reiss AL, King MK, Abbeduto L, Kaufmann WE. Updated report on tools to measure outcomes of clinical trials in fragile X syndrome. Journal of Neurodevelopmental Disorders. 9: 14. PMID 28616097 DOI: 10.1186/s11689-017-9193-x |
0.348 |
|
| 2017 |
Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. Journal of Neurodevelopmental Disorders. 9: 11. PMID 28316753 DOI: 10.1186/S11689-017-9191-Z |
0.349 |
|
| 2016 |
Li J, Qiu L, Xu L, Pedapati EV, Erickson CA, Sunar U. Characterization of autism spectrum disorder with spontaneous hemodynamic activity. Biomedical Optics Express. 7: 3871-3881. PMID 27867699 DOI: 10.1364/Boe.7.003871 |
0.349 |
|
| 2016 |
Yoon Y, Wink LK, Pedapati EV, Horn PS, Erickson CA. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27389348 DOI: 10.1089/cap.2016.0049 |
0.382 |
|
| 2016 |
Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA. Aggression in autism spectrum disorder: presentation and treatment options. Neuropsychiatric Disease and Treatment. 12: 1525-38. PMID 27382295 DOI: 10.2147/NDT.S84585 |
0.475 |
|
| 2016 |
Erickson CA, Wink LK, Baindu B, Ray B, Schaefer TL, Pedapati EV, Lahiri D. Analysis of peripheral amyloid precursor protein in Angelman Syndrome. American Journal of Medical Genetics. Part A. PMID 27327493 DOI: 10.1002/Ajmg.A.37811 |
0.428 |
|
| 2016 |
Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Molecular Autism. 7: 26. PMID 27103982 DOI: 10.1186/S13229-016-0088-6 |
0.459 |
|
| 2016 |
Pedapati EV, Gilbert DL, Erickson CA, Horn PS, Shaffer RC, Wink LK, Laue CS, Wu SW. Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot Study. Journal of Child and Adolescent Psychopharmacology. PMID 27007257 DOI: 10.1089/cap.2015.0183 |
0.445 |
|
| 2016 |
Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, Hurwitz S, McDougle CJ, Swiezy NB, Erickson CA. A randomized, placebo-controlled trial of d-cycloserine for the enhancement of social skills training in autism spectrum disorders. Molecular Autism. 7: 2. PMID 26770664 DOI: 10.1186/S13229-015-0062-8 |
0.347 |
|
| 2015 |
Siegel M, Smith KA, Mazefsky C, Gabriels RL, Erickson C, Kaplan D, Morrow EM, Wink L, Santangelo SL. The autism inpatient collection: methods and preliminary sample description. Molecular Autism. 6: 61. PMID 26557975 DOI: 10.1186/S13229-015-0054-8 |
0.344 |
|
| 2015 |
Wink LK, Pedapati EV, Horn PS, McDougle CJ, Erickson CA. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26465194 DOI: 10.1089/cap.2015.0123 |
0.424 |
|
| 2015 |
Wink LK, Fitzpatrick S, Shaffer R, Melnyk S, Begtrup AH, Fox E, Schaefer TL, Mathieu-Frasier L, Ray B, Lahiri D, Horn PA, Erickson CA. The neurobehavioral and molecular phenotype of Angelman syndrome. American Journal of Medical Genetics. Part A. PMID 26219744 DOI: 10.1002/Ajmg.A.37254 |
0.439 |
|
| 2015 |
Dominick K, Wink LK, McDougle CJ, Erickson CA. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 25: 397-401. PMID 26091194 DOI: 10.1089/cap.2014.0111 |
0.57 |
|
| 2015 |
Hulvershorn LA, Schroeder KM, Wink LK, Erickson CA, McDougle CJ. Psychopharmacologic treatment of children prenatally exposed to drugs of abuse. Human Psychopharmacology. 30: 164-72. PMID 25737371 DOI: 10.1002/hup.2467 |
0.329 |
|
| 2015 |
Bowers K, Lin PI, Erickson C. Pharmacogenomic medicine in autism: challenges and opportunities. Paediatric Drugs. 17: 115-24. PMID 25420674 DOI: 10.1007/S40272-014-0106-0 |
0.37 |
|
| 2015 |
Bowers K, Wink LK, Pottenger A, McDougle CJ, Erickson C. Phenotypic differences in individuals with autism spectrum disorder born preterm and at term gestation. Autism : the International Journal of Research and Practice. 19: 758-63. PMID 25192860 DOI: 10.1177/1362361314547366 |
0.49 |
|
| 2015 |
Adler BA, Wink LK, Early M, Shaffer R, Minshawi N, McDougle CJ, Erickson CA. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism : the International Journal of Research and Practice. 19: 102-6. PMID 24571823 DOI: 10.1177/1362361314524641 |
0.454 |
|
| 2014 |
Erickson CA, Ray B, Maloney B, Wink LK, Bowers K, Schaefer TL, McDougle CJ, Sokol DK, Lahiri DK. Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. Journal of Psychiatric Research. 59: 220-8. PMID 25300441 DOI: 10.1016/J.Jpsychires.2014.07.011 |
0.45 |
|
| 2014 |
Wink LK, O'Melia AM, Shaffer RC, Pedapati E, Friedmann K, Schaefer T, Erickson CA. Intranasal ketamine treatment in an adult with autism spectrum disorder. The Journal of Clinical Psychiatry. 75: 835-6. PMID 25191906 DOI: 10.4088/JCP.13cr08917 |
0.44 |
|
| 2014 |
Wink LK, Early M, Schaefer T, Pottenger A, Horn P, McDougle CJ, Erickson CA. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole. Journal of Child and Adolescent Psychopharmacology. 24: 78-82. PMID 24564519 DOI: 10.1089/cap.2013.0099 |
0.337 |
|
| 2014 |
Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. Journal of Autism and Developmental Disorders. 44: 958-64. PMID 24272415 DOI: 10.1007/S10803-013-1963-Z |
0.487 |
|
| 2014 |
Erickson CA, Wink LK, Early MC, Stiegelmeyer E, Mathieu-Frasier L, Patrick V, McDougle CJ. Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder. Journal of Autism and Developmental Disorders. 44: 981-7. PMID 24052275 DOI: 10.1007/s10803-013-1943-3 |
0.426 |
|
| 2013 |
Lahiri DK, Sokol DK, Erickson C, Ray B, Ho CY, Maloney B. Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway. Frontiers in Cellular Neuroscience. 7: 94. PMID 23801940 DOI: 10.3389/Fncel.2013.00094 |
0.368 |
|
| 2013 |
Erickson CA, Wink LK, Ray B, Early MC, Stiegelmeyer E, Mathieu-Frasier L, Patrick V, Lahiri DK, McDougle CJ. Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome. Psychopharmacology. 228: 75-84. PMID 23436129 DOI: 10.1007/S00213-013-3022-Z |
0.381 |
|
| 2012 |
Ho JG, Caldwell RL, McDougle CJ, Orsagh-Yentis DK, Erickson CA, Posey DJ, Stigler KA. The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 22: 277-83. PMID 22849533 DOI: 10.1089/cap.2011.0129 |
0.369 |
|
| 2012 |
Stigler KA, Mullett JE, Erickson CA, Posey DJ, McDougle CJ. Paliperidone for irritability in adolescents and young adults with autistic disorder. Psychopharmacology. 223: 237-45. PMID 22549762 DOI: 10.1007/s00213-012-2711-3 |
0.44 |
|
| 2011 |
Orsagh-Yentis DK, Wink LK, Stigler KA, Erickson CA, McDougle CJ. Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified. Journal of Child and Adolescent Psychopharmacology. 21: 643-5. PMID 22136097 DOI: 10.1089/cap.2010.0137 |
0.43 |
|
| 2011 |
Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone palmitate in a child with autistic disorder. Journal of Child and Adolescent Psychopharmacology. 21: 491-3. PMID 22040196 DOI: 10.1089/cap.2011.0035 |
0.435 |
|
| 2011 |
Wink LK, Erickson CA, Stigler KA, McDougle CJ. Riluzole in autistic disorder. Journal of Child and Adolescent Psychopharmacology. 21: 375-9. PMID 21823915 DOI: 10.1089/cap.2010.0154 |
0.516 |
|
| 2011 |
Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Guanfacine extended release in two patients with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 21: 287-90. PMID 21663433 DOI: 10.1089/cap.2010.0057 |
0.35 |
|
| 2011 |
Erickson CA, Stigler KA, Wink LK, Mullett JE, Kohn A, Posey DJ, McDougle CJ. A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology. 216: 85-90. PMID 21318565 DOI: 10.1007/s00213-011-2194-7 |
0.323 |
|
| 2010 |
Blankenship K, Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years. Pediatric Health. 4: 375-381. PMID 21359119 DOI: 10.2217/phe.10.45 |
0.368 |
|
| 2010 |
Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treatment Options in Neurology. 12: 529-38. PMID 20848330 DOI: 10.1007/s11940-010-0091-8 |
0.462 |
|
| 2010 |
Wink LK, Erickson CA, Chambers JE, McDougle CJ. Co-morbid intellectual disability and borderline personality disorder: a case series. Psychiatry. 73: 277-87. PMID 20843219 DOI: 10.1521/psyc.2010.73.3.277 |
0.359 |
|
| 2010 |
Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Aripiprazole in autism spectrum disorders and fragile X syndrome. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 258-63. PMID 20643378 DOI: 10.1016/j.nurt.2010.04.001 |
0.592 |
|
| 2010 |
Wink LK, Plawecki MH, Erickson CA, Stigler KA, McDougle CJ. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opinion On Emerging Drugs. 15: 481-94. PMID 20470188 DOI: 10.1517/14728214.2010.487860 |
0.579 |
|
| 2010 |
Stigler KA, Erickson CA, Mullett JE, Posey DJ, McDougle CJ. Paliperidone for irritability in autistic disorder. Journal of Child and Adolescent Psychopharmacology. 20: 75-8. PMID 20166801 DOI: 10.1089/cap.2009.0019 |
0.524 |
|
| 2009 |
Stigler KA, Diener JT, Kohn AE, Li L, Erickson CA, Posey DJ, McDougle CJ. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. Journal of Child and Adolescent Psychopharmacology. 19: 265-74. PMID 19519261 DOI: 10.1089/cap.2008.093 |
0.469 |
|
| 2008 |
McDougle CJ, Stigler KA, Erickson CA, Posey DJ. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. The Journal of Clinical Psychiatry. 69: 15-20. PMID 18533764 |
0.342 |
|
| 2007 |
Erickson CA, Posey DJ, Stigler KA, McDougle CJ. Pharmacologic treatment of autism and related disorders. Pediatric Annals. 36: 575-85. PMID 17910205 |
0.473 |
|
| 2007 |
Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology. 191: 141-7. PMID 17016714 DOI: 10.1007/s00213-006-0518-9 |
0.315 |
|
| 2006 |
Erickson CA, Chambers JE. Memantine for disruptive behavior in autistic disorder. The Journal of Clinical Psychiatry. 67: 1000. PMID 16848669 |
0.449 |
|
| 2006 |
Posey DJ, Erickson CA, Stigler KA, McDougle CJ. The use of selective serotonin reuptake inhibitors in autism and related disorders. Journal of Child and Adolescent Psychopharmacology. 16: 181-6. PMID 16553538 DOI: 10.1089/cap.2006.16.181 |
0.364 |
|
| 2005 |
McDougle CJ, Erickson CA, Stigler KA, Posey DJ. Neurochemistry in the pathophysiology of autism. The Journal of Clinical Psychiatry. 66: 9-18. PMID 16401145 |
0.526 |
|
| 2005 |
Erickson CA, Stigler KA, Posey DJ, McDougle CJ. Risperidone in pervasive developmental disorders. Expert Review of Neurotherapeutics. 5: 713-9. PMID 16274329 DOI: 10.1586/14737175.5.6.713 |
0.514 |
|
| 2005 |
Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ. Gastrointestinal factors in autistic disorder: a critical review. Journal of Autism and Developmental Disorders. 35: 713-27. PMID 16267642 DOI: 10.1007/s10803-005-0019-4 |
0.364 |
|
| Show low-probability matches. |